Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check20 days agoChange DetectedThe site revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 is displayed on the page, with no changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now shows Revision: v3.4.1 instead of Revision: v3.4.0. This is a metadata update at the top of the page and does not affect study content.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded UI and metadata changes: a Show glossary option appears, and new labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' are shown. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or updated.SummaryDifference0.3%

- Check78 days agoChange DetectedThe page now displays Revision: v3.3.4 instead of v3.3.3. This is a metadata update with no visible changes to the study details or layout; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.